Sodium fluoride


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
Narayana and Chinoy., 1994IVR10 mg/kg 10 mg/kgAlterations in number of leydig cellsReproductive endocrine-mediated perturbations
IVR10 mg/kg 10 mg/kgDecreased testosterone levelsReproductive endocrine-mediated perturbations
PMID:27572304IVR50 mg/L 50 mg/LAffects testis developmentDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR50 mg/L 50 mg/LAffects neuronal signalingNeurological endocrine-mediated perturbations
IVR50 mg/L 50 mg/LAlterations in immune responsesImmunological endocrine-mediated perturbations
IVR100 mg/L 100 mg/LAffects neuronal signalingNeurological endocrine-mediated perturbations
IVR100 mg/L 100 mg/LAffects testis developmentDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR100 mg/L 100 mg/LAlterations in immune responsesImmunological endocrine-mediated perturbations
PMID:29323457IVR50 mg/kg 50 mg/kgAffects expression of estrogen receptor-alpha (ER-alpha)Reproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.